Search Results
Jan 29, 2026, 04:29 ET Corcept Therapeutics Incorporated Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights - CORT
CORT) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements
More news about: DJS Law Group LLP
Jan 22, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Corcept Therapeutics Incorporated ("Corcept" or the "Company") (NASDAQ: CORT). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Jan 21, 2026, 18:36 ET CORT INVESTIGATION ALERT: Investigation Launched into Corcept Therapeutics (CORT), Hagens Berman Encourages Investors to Contact Firm
www.hbsslaw.com/investor-fraud/cortContact the Firm Now: [email protected] 844-916-0895Corcept Therapeutics (CORT) Investigation:
More news about: Hagens Berman Sobol Shapiro LLP
Jan 15, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Corcept Therapeutics Incorporated ("Corcept" or the "Company") (NASDAQ: CORT). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Jan 15, 2026, 01:29 ET CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm
CORT) for violations of the securities laws.
More news about: The Schall Law Firm
Jan 14, 2026, 11:56 ET Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% - Hagens Berman
www.hbsslaw.com/investor-fraud/cort Contact the Firm Now: [email protected] 844-916-0895Corcept Therapeutics (CORT) Investigation:
More news about: Hagens Berman Sobol Shapiro LLP
Jan 08, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Corcept Therapeutics Incorporated ("Corcept" or the "Company") (NASDAQ: CORT). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Jan 06, 2026, 12:01 ET Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% - Hagens Berman
www.hbsslaw.com/investor-fraud/cortContact the Firm Now: [email protected] 844-916-0895Corcept Therapeutics (CORT) Investigation:
More news about: Hagens Berman Sobol Shapiro LLP
Dec 15, 2025, 16:18 ET Alger Russell Innovation Index Updates for Fourth Quarter 2025
Corcept Therapeutics Inc. CORTDeletion
More news about: Alger
Dec 09, 2025, 17:31 ET Amyotrophic Lateral Sclerosis Market Outlook: Expanding Therapeutic Pipeline and Novel Drug Launches Propel Growth Throughout Forecast Period (2025-2034) | DelveInsight
(ION363), IBUDILAST, ABBV-CLS-7262, CNM-AU8, SLS-005 (TREHALOSE), PRIDOPIDINE, RAPA-501, PrimeC, ENGENSIS (VM202), TPN-101, RNS60, ANX005, DAZUCORILANT (CORT113176), AP-101, AIT-101 (LAM-002A), NP001, IFB-088, and others.Brainstorm-Cell Therapeutics's NurOwn and Rapa Therapeutics's RAPA 501 are
More news about: DelveInsight Business Research, LLP
Nov 17, 2025, 05:26 ET Corporate Event Services in U.S Market to Reach $57.86 Billion, by 2035 at 6.3% CAGR: Allied Market Research
Mosaic Events Jack Morton Worldwide Inc. Eventdrive CORT AFR Event Rental Moss Ticket Falcon Eventbee,
More news about: Allied Market Research
Nov 13, 2025, 14:37 ET Waste Pro USA, Inc. Announces the Issuance of Solid Waste Disposal Revenue Bonds in the aggregate principal amount of $200.0 million
financial strength and future growth strategy. Their trust reinforces our commitment to delivering sustainable value and disciplined growth," added Cort Sabina, Chief Financial Officer of Waste Pro. "This transaction, which was significantly oversold, was broadly supported by over twenty new and existing
More news about: Waste Pro USA, Inc.
Oct 09, 2025, 17:31 ET Platinum-Resistant Ovarian Cancer Treatment Market Sees Momentum with Next-Generation Targeted Strategies | DelveInsight
coming years. The promising platinum-resistant ovarian cancer therapies in clinical trials include Relacorilant (CORT125134), Catequentinib (Anlotinib), Ubamatamab (REGN4018) ± Cemiplimab, Afuresertib (LAE002) + Paclitaxel, and others.
More news about: DelveInsight Business Research, LLP
Sep 15, 2025, 16:25 ET Alger Russell Innovation Index Updates for Third Quarter 2025
Corcept Therapeutics, Inc. CORT Addition
More news about: Alger